VXRT - If You Invested $5000 in Vaxart In January This Is How Much You Would Have Today
At the start of the year, Vaxart (NASDAQ: VXRT) was a biotech company with a market cap of about $17 million and a stock price of less than $1. Once the company entered the coronavirus vaccine race, however, its fortunes -- and those of its investors -- changed. The stock climbed as much as 4,600% to its peak in July, and its market value rose to as much as $1.8 billion.
If you invested $5,000 on Jan. 2 when the stock was trading at $0.36 and then sold at the high point this summer, you would have made $230,696. The stock has since pared its gains; rivals moved closer to the coronavirus vaccine finish line and Vaxart didn't receive Operation Warp Speed (OWS) funding as some investors had hoped. OWS is the White House's initiative to help bring a coronavirus vaccine to market. Ten programs are in phase 3 studies; Vaxart recently announced the start of its phase 1 trial. If you held onto your Vaxart investment, today you would have $78,334. Whether you sold in July or held on, you still have something to smile about. Now the question is: Are more gains on the horizon? Let's take a look at where things stand for this biotech company.
Image source: Getty Images.
For further details see:
If You Invested $5,000 in Vaxart In January, This Is How Much You Would Have Today